BioTek's Cytation 3 Cell Imaging Multi-Mode Reader is finalist in 2014 Edison Awards competition

NewsGuard 100/100 Score

BioTek Instruments, Inc., proudly announces that their Cytation™ 3 Cell Imaging Multi-Mode Reader is a finalist in the 2014 Edison Awards® competition. The distinguished awards, inspired by Thomas Edison's persistence and inventiveness, recognize innovation, creativity and ingenuity in the global economy. Award winners will be announced April 30, 2014 at the Edison Awards Annual Gala, held in the historic Julia Morgan Ballroom in San Francisco, CA.

Cytation 3 is among those finalists recognized by a distinguished panel of senior business executives and academics for innovation and excellence. Patented Cytation 3 combines automated digital microscopy and conventional multi-mode microplate detection to provide both rich phenotypic and well-based quantitative analyses in a streamlined workflow. This unique, parallel data acquisition platform is ideal for both cell-based and biochemical assays, and its modular architecture allows users to select the modes they need now, and easily upgrade as their needs evolve.

Peter Weith, BioTek Vice President of Marketing, Sales and Service noted, "We're honored that our Cytation 3 is recognized as an innovation by our customers and the prestigious Edison Awards, and we will continue to develop new, innovative solutions for our customers' challenges."

"It's exciting to see companies like BioTek continuing Thomas Edison's legacy of challenging conventional thinking," added Frank Bonafilia, Edison Awards' executive director. "Edison Awards recognizes the game changing products and services, and the teams that brought them to consumers."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthroughs in germline-targeting HIV vaccine design for broad protection